The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Attenuated FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for the Koreans (Asian population) with gemcitabine-resistant or –refractory advanced pancreatic cancer.
 
Sang-Cheol Lee
No Relationships to Disclose
 
Jung Hoon Kim
No Relationships to Disclose
 
Sung Yong Oh
No Relationships to Disclose
 
Kyoungha Kim
No Relationships to Disclose
 
Seo-Young Song
No Relationships to Disclose
 
Namsu Lee
No Relationships to Disclose
 
Eun Mi Nam
No Relationships to Disclose
 
Soonil Lee
No Relationships to Disclose
 
In Gyu Hwang
No Relationships to Disclose
 
Hyo Rak Lee
No Relationships to Disclose
 
Jong-Ho Won
No Relationships to Disclose
 
Kyu Taek Lee
No Relationships to Disclose
 
Sang-Byung Bae
No Relationships to Disclose
 
Hanjo Kim
No Relationships to Disclose
 
Hyun Jung Kim
No Relationships to Disclose
 
JoungSoon Jang
No Relationships to Disclose
 
Do Hyoung Lim
No Relationships to Disclose
 
Hyun Woo Lee
No Relationships to Disclose
 
Jung Hun Kang
No Relationships to Disclose